Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003574 · ClinicalTrials.gov registry record · Phase 2
Radiation Therapy in Treating Patients With Progressive or Recurrent Malignant Brain Tumors
A Phase 2 study, sponsored by New Approaches to Brain Tumor Therapy Consortium.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00003574: Completed Phase 2 study, sponsored by New Approaches to Brain Tumor Therapy Consortium.
NCT00003574 is a Phase 2 study that has completed, run by New Approaches to Brain Tumor Therapy Consortium. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00003574, a Phase 2 study, has completed, sponsored by New Approaches to Brain Tumor Therapy Consortium.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Giving radiation therapy in different ways may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of radiation therapy in treating patients who are undergoing surgical removal of progressive or recurrent malignant brain tumors.
Interventions
- RADIATION brachytherapy
- PROCEDURE surgical procedure
- RADIATION iodine I 125
- RADIATION intraoperative radiation therapy
Trial Details
| Field | Value |
|---|---|
| Start Date | 1999-04 |
| Est. Completion | 2004-06 |
| Phase | Phase 2 |
What the finished NCT00003574 record still lists
NCT00003574 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 4 interventions - of which brachytherapy is the first listed.
NCT00003574 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00003574 about?
NCT00003574 is a clinical study titled "Radiation Therapy in Treating Patients With Progressive or Recurrent Malignant Brain Tumors". RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Giving radiation therapy in different ways may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of radiation therapy in treating patients who are undergoing surgical removal of progressive or recurr...
What is the current status of trial NCT00003574?
This trial is currently completed. It is a Phase 2 study. The study started on 1999-04. Estimated completion is 2004-06.
What interventions are being tested in trial NCT00003574?
The interventions under investigation include: brachytherapy (RADIATION), surgical procedure (PROCEDURE), iodine I 125 (RADIATION), intraoperative radiation therapy (RADIATION).
Who is sponsoring clinical trial NCT00003574?
This trial is sponsored by New Approaches to Brain Tumor Therapy Consortium, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia